April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Ultrasound Biomicroscopy to Visualize Suprachoroidal Injections in Enucleated Human Eyes
Author Affiliations & Notes
  • Jesse Yoo
    Clearside Biomedical Inc., Alpharetta, GA
  • Rafael Andino
    Clearside Biomedical Inc., Alpharetta, GA
  • Vladimir Zarnitsyn
    Clearside Biomedical Inc., Alpharetta, GA
  • Keleigh Strudthoff
    Clearside Biomedical Inc., Alpharetta, GA
  • Samirkumar Rajnikant Patel
    Clearside Biomedical Inc., Alpharetta, GA
  • Henry F Edelhauser
    Clearside Biomedical Inc., Alpharetta, GA
    Ophthalmology, Emory Univ Eye Center, Atlanta, GA
  • Footnotes
    Commercial Relationships Jesse Yoo, Clearside Biomedical (E); Rafael Andino, Clearside Biomedical (E), Clearside Biomedical (P); Vladimir Zarnitsyn, Clearside Biomedical (E), Clearside Biomedical (I), Clearside Biomedical (P); Keleigh Strudthoff, Clearside Biomedical (E); Samirkumar Patel, Clearside Biomedical (E), Clearside Biomedical (I), Clearside Biomedical (P); Henry Edelhauser, Clearside Biomedical (C), Clearside Biomedical (I), Clearside Biomedical (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5253. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jesse Yoo, Rafael Andino, Vladimir Zarnitsyn, Keleigh Strudthoff, Samirkumar Rajnikant Patel, Henry F Edelhauser; Ultrasound Biomicroscopy to Visualize Suprachoroidal Injections in Enucleated Human Eyes. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5253.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose: The purpose of this study was to assess if ultrasound biomicroscopy (UBM) is a viable imaging tool to characterize suprachoroidal injections.

Methods: Four enucleated human globes (Georgia Eye Bank, Atlanta GA) from two donors were received within 6 hours from time of death. Each globe received 4, 50µl injections of 40 mg/mL triamcinolone acetonide suspension (Clearside Biomedical Inc., Alpharetta GA). Suprachoroidal injections were performed with a microneedle (Clearside Biomedical Inc., Alpharetta GA) at 6-8 mm posterior to the limbus within each quadrant of the globe. Images of the injection sites were taken pre and post-injection using a UBM probe (UBM Plus, Accutome, Malvern,PA). Images were compared to determine if there was an expansion of the layers of the eye (conjunctiva, sclera, choroid, and retina).

Results: The UBM imaging demonstrated a clear distinction between pre- and post-images. Conjunctival thickness ranged from 0.130 - 0.320 mm. Scleral thicknesses ranged from 0.6-1.2 mm pre-injection and increased on average by 0.3 mm post-injection. Post-injection images revealed a hypoechoic region with low ultrasound reflectivity in the lower half of the sclera closest to the choroid. The combination of scleral thickness increase and the presence of the hypoechoic region was evidence of the suprachoroidal injection. Suprachoroidal injections were confirmed at all sites.

Conclusions: Suprachoroidal delivery can be confirmed using UBM through visualization of the suprachoroidal space and expansion of the sclera.

Keywords: 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • 708 sclera • 419 anatomy  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×